Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aldo Scarpa

Showing results (321-330 of 602) with videos related to

Pageof 61
Sort By:
Journal of Personalized Medicine|September 28, 2023
Revolutionizing Cancer Research: The Impact of Artificial Intelligence in Digital BiobankingChiara Frascarelli, Giuseppina Bonizzi, Camilla Rosella Musico, et al.
Human Mutation|May 23, 2009
Molecular profiling of the "plexinome" in melanoma and pancreatic cancerAsha Balakrishnan, Junia Y Penachioni, Simona Lamba, et al.
Clinical Breast Cancer|July 19, 2014
Human epidermal growth factor receptor 2-positive breast cancer: heat shock protein 90 overexpression, Ki67 proliferative index, and topoisomerase II-α co-amplification as predictors of pathologic complete response to neoadjuvant chemotherapy with trastuzumab and docetaxelEmilio Bria, Jenny Furlanetto, Luisa Carbognin, et al.
Pancreas|February 13, 2014
Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcomeFrancesco Panzuto, Elettra Merola, Maria Rinzivillo, et al.
Annals of Surgical Oncology|October 13, 2022
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal AdenocarcinomaLaura Maggino, Giuseppe Malleo, Stefano Crippa, et al.
Targeted Oncology|September 1, 2018
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate CancerRoberto Iacovelli, Chiara Ciccarese, Claudia Mosillo, et al.
EMBO Molecular Medicine|June 27, 2018
Soluble stroma-related biomarkers of pancreatic cancerAndrea Resovi, Maria Rosa Bani, Luca Porcu, et al.
Annals of Surgical Oncology|April 21, 2020
Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal AdenocarcinomaGiuseppe Malleo, Laura Maggino, Cristina R Ferrone, et al.
Genome Medicine|January 15, 2015
A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinomaSyed Haider, Jun Wang, Ai Nagano, et al.
BMC Cancer|March 9, 2016
Characterization of various cell lines from different ampullary cancer subtypes and cancer associated fibroblast-mediated responsesZon Weng Lai, Louisa Bolm, Hannah Fuellgraf, et al.
Pageof 61

Showing results (321-330 of 602) with videos related to

Sort By:
Pageof 61
Journal of Personalized Medicine|September 28, 2023
Revolutionizing Cancer Research: The Impact of Artificial Intelligence in Digital BiobankingChiara Frascarelli, Giuseppina Bonizzi, Camilla Rosella Musico, et al.
Human Mutation|May 23, 2009
Molecular profiling of the "plexinome" in melanoma and pancreatic cancerAsha Balakrishnan, Junia Y Penachioni, Simona Lamba, et al.
Clinical Breast Cancer|July 19, 2014
Human epidermal growth factor receptor 2-positive breast cancer: heat shock protein 90 overexpression, Ki67 proliferative index, and topoisomerase II-α co-amplification as predictors of pathologic complete response to neoadjuvant chemotherapy with trastuzumab and docetaxelEmilio Bria, Jenny Furlanetto, Luisa Carbognin, et al.
Pancreas|February 13, 2014
Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcomeFrancesco Panzuto, Elettra Merola, Maria Rinzivillo, et al.
Annals of Surgical Oncology|October 13, 2022
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal AdenocarcinomaLaura Maggino, Giuseppe Malleo, Stefano Crippa, et al.
Targeted Oncology|September 1, 2018
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate CancerRoberto Iacovelli, Chiara Ciccarese, Claudia Mosillo, et al.
EMBO Molecular Medicine|June 27, 2018
Soluble stroma-related biomarkers of pancreatic cancerAndrea Resovi, Maria Rosa Bani, Luca Porcu, et al.
Annals of Surgical Oncology|April 21, 2020
Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal AdenocarcinomaGiuseppe Malleo, Laura Maggino, Cristina R Ferrone, et al.
Genome Medicine|January 15, 2015
A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinomaSyed Haider, Jun Wang, Ai Nagano, et al.
BMC Cancer|March 9, 2016
Characterization of various cell lines from different ampullary cancer subtypes and cancer associated fibroblast-mediated responsesZon Weng Lai, Louisa Bolm, Hannah Fuellgraf, et al.
Pageof 61